Stock data
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI) reported revenue of US$1.63M and net income of -US$29.67M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.63M | — | -US$38.31M | -US$29.67M | — |
| 2024 | US$1.03M | — | -US$53.31M | -US$30.02M | — |
| 2023 | US$0.00M | — | -US$66.10M | -US$33.97M | — |
| 2022 | US$0.00M | — | -US$63.45M | -US$30.59M | — |
| 2021 | US$2.72M | — | -US$51.60M | -US$8.33M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.71M | -US$7.39M | — |
| 2026-03-31 | US$1.71M | -US$7.03M | — |
| 2025-12-31 | US$1.46M | -US$10.30M | — |
| 2025-09-30 | US$0.00M | -US$5.41M | — |
| 2025-06-30 | US$0.00M | -US$6.69M | — |
| 2025-03-31 | US$0.17M | -US$7.26M | — |
| 2024-12-31 | US$1.03M | -US$8.95M | — |
| 2024-09-30 | US$0.00M | -US$6.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.